Page last updated: 2024-09-04

docetaxel anhydrous and apicidin

docetaxel anhydrous has been researched along with apicidin in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (apicidin)	Trials (apicidin)	Recent Studies (post-2010) (apicidin)
12,110	3,216	6,920	117	0	48

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belardelli, F; Borghi, P; Buoncervello, M; Gabriele, L; Romagnoli, G; Spadaro, F; Toschi, E	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and apicidin

Article	Year
Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells. Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Dendritic Cells; DNA-Binding Proteins; Docetaxel; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Immunomodulation; Neoplasm Metastasis; Peptides, Cyclic; Taxoids	2012

Article

Year

Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.

Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Dendritic Cells; DNA-Binding Proteins; Docetaxel; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Immunomodulation; Neoplasm Metastasis; Peptides, Cyclic; Taxoids

2012